Progyny, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Progyny, Inc. (PGNY) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $7.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-07
- Progyny, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $6.45M.
- Progyny, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $1.53M, a 91.26% decline year-over-year.
- Progyny, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was -$12.90M.
- Progyny, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $7.46M, a 74.74% increase year-over-year.
- Progyny, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $417.00K, a 95.80% decline from fiscal 2024.
- Progyny, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $9.92M, a 4.22% decline from fiscal 2023.
- Progyny, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $10.36M, a 21.19% decline from fiscal 2022.
- Progyny, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $13.15M, a 501.97% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $7.98M 10-Q · filed 2026-08-07 | -$4.92M derived: sum of 3 quarters · filed 2026-08-07 | $2.54M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $1.53M 10-Q · filed 2026-05-08 | -$11.37M derived: sum of 2 quarters · filed 2026-05-08 | -$3.90M derived: sum of 3 quarters · filed 2026-05-08 | -$15.56M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$12.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$5.43M derived: sum of 2 quarters · filed 2026-02-27 | -$17.09M derived: sum of 3 quarters · filed 2026-08-07 | $417.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | $7.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$4.19M derived: sum of 2 quarters · filed 2026-08-07 | $13.32M 10-Q · filed 2025-11-07 | $10.11M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$11.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $5.85M 10-Q · filed 2026-08-07 | $2.64M derived: sum of 3 quarters · filed 2026-08-07 | $6.92M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $17.51M 10-Q · filed 2026-05-08 | $14.30M derived: sum of 2 quarters · filed 2026-05-08 | $18.57M derived: sum of 3 quarters · filed 2026-05-08 | $14.44M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.06M derived: sum of 2 quarters · filed 2026-02-27 | -$3.07M derived: sum of 3 quarters · filed 2026-02-27 | $9.92M 10-K · filed 2026-02-27 |
| 2024-09-30 | $4.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $137.00K derived: sum of 2 quarters · filed 2025-11-07 | $13.13M 10-Q · filed 2025-11-07 | $11.75M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$4.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $8.86M 10-Q · filed 2025-08-08 | $7.48M derived: sum of 3 quarters · filed 2026-02-27 | $5.39M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $12.99M 10-Q · filed 2025-05-09 | $11.61M derived: sum of 2 quarters · filed 2026-02-27 | $9.53M derived: sum of 3 quarters · filed 2026-02-27 | $11.61M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$3.47M derived: sum of 2 quarters · filed 2026-02-27 | -$1.39M derived: sum of 3 quarters · filed 2026-02-27 | $10.36M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$7.00K derived: sum of 2 quarters · filed 2024-11-12 | $11.74M 10-Q · filed 2024-11-12 | $8.56M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $13.83M 10-Q · filed 2024-08-07 | $10.65M derived: sum of 3 quarters · filed 2025-03-03 | $11.38M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $11.75M 10-Q · filed 2024-05-10 | $8.57M derived: sum of 2 quarters · filed 2025-03-03 | $9.31M derived: sum of 3 quarters · filed 2025-03-03 | $18.41M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$2.44M derived: sum of 2 quarters · filed 2025-03-03 | $6.66M derived: sum of 3 quarters · filed 2025-03-03 | $13.15M 10-K · filed 2025-03-03 |
| 2022-09-30 | $739.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $9.84M derived: sum of 2 quarters · filed 2023-11-08 | $16.33M 10-Q · filed 2023-11-08 | $5.42M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $9.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $15.59M 10-Q · filed 2023-08-04 | $4.69M derived: sum of 3 quarters · filed 2024-02-29 | $8.24M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $6.49M 10-Q · filed 2023-05-09 | -$4.42M derived: sum of 2 quarters · filed 2024-02-29 | -$864.00K derived: sum of 3 quarters · filed 2024-02-29 | -$740.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$10.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$7.35M derived: sum of 2 quarters · filed 2024-02-29 | -$7.23M derived: sum of 3 quarters · filed 2024-02-29 | $2.18M 10-K · filed 2024-02-29 |
| 2021-09-30 | $3.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $3.68M derived: sum of 2 quarters · filed 2022-11-04 | $13.09M 10-Q · filed 2022-11-04 | $15.47M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $9.54M 10-Q · filed 2022-08-05 | $11.92M derived: sum of 3 quarters · filed 2023-03-01 | $18.47M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $9.41M 10-Q · filed 2022-05-06 | $11.79M derived: sum of 2 quarters · filed 2023-03-01 | $18.34M derived: sum of 3 quarters · filed 2023-03-01 | $23.56M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $8.93M derived: sum of 2 quarters · filed 2023-03-01 | $14.14M derived: sum of 3 quarters · filed 2023-03-01 | $17.40M 10-K · filed 2023-03-01 |
| 2020-09-30 | $6.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $11.76M derived: sum of 2 quarters · filed 2021-11-08 | $15.02M 10-Q · filed 2021-11-08 | $15.29M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $5.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $8.47M 10-Q · filed 2021-08-06 | $8.74M derived: sum of 3 quarters · filed 2022-03-01 | $10.76M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $3.26M 10-Q · filed 2021-05-07 | $3.52M derived: sum of 2 quarters · filed 2022-03-01 | $5.54M derived: sum of 3 quarters · filed 2022-03-01 | $6.75M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $266.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.29M derived: sum of 2 quarters · filed 2022-03-01 | $3.50M derived: sum of 3 quarters · filed 2022-03-01 | $6.38M 10-K · filed 2022-03-01 |
| 2019-09-30 | $2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $3.23M derived: sum of 2 quarters · filed 2020-11-06 | $6.12M 10-Q · filed 2020-11-06 | $4.45M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $4.10M 10-Q · filed 2020-08-07 | $2.43M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-03-31 | $2.89M 10-Q · filed 2020-05-14 | $1.22M derived: sum of 2 quarters · filed 2021-03-01 | ||
| 2018-12-31 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $2.76M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $4.43M 10-Q · filed 2019-12-06 | |||
| 2017-12-31 | $2.00M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |